Y-Intercept (HK)
PYXS icon

Y-Intercept (HK)’s Pyxis Oncology PYXS Stock Holding History

Y-Intercept (HK)’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.6K Buy
+20,878
New +$63.2K ﹤0.01% 1524
2025
Q3 		– Sell
-133,047
Closed -$146K – 1948
2025
Q2 		$146K Buy
+133,047
New +$150K ﹤0.01% 1502
2024
Q2 		– Sell
-28,053
Closed -$120K – 1815
2024
Q1 		$120K Buy
+28,053
New +$118K 0.01% 1258

Other funds holding PYXS

T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $159M AUM 18.68% 1-Year Est. Return
First United Bank & Trust
First United Bank & Trust Oakland, Maryland $347M AUM 18.04% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Mainstream Capital Management
Mainstream Capital Management Los Angeles, California $170M AUM 21% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Y-Intercept (HK)'s PYXS Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 20,878 shares worth $48.6K. The stake represents ﹤0.01% of the portfolio and ranks #1524 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in PYXS as recently as Q2 2025.

Y-Intercept (HK) first reported a position in PYXS in Q1 2024 and has held it in 3 quarters since. The position peaked at $146K in Q2 2025. 9 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • Y-Intercept (HK) held 20,878 shares of Pyxis Oncology worth $48.6K as of Q3 2026.
  • Pyxis Oncology was a new Y-Intercept (HK) position in Q3 2026.
  • Pyxis Oncology made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1524 holding.
  • Y-Intercept (HK) first reported a position in Pyxis Oncology in Q1 2024 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s Pyxis Oncology position peaked at $146K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.